REMIFENTANIL

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H28N2O5
Molecular Weight	376.4467
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCC(=O)N(C1=CC=CC=C1)C2(CCN(CCC(=O)OC)CC2)C(=O)OC

InChI

InChIKey=ZTVQQQVZCWLTDF-UHFFFAOYSA-N

InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3

HIDE SMILES / InChI

Molecular Formula	C20H28N2O5
Molecular Weight	376.4467
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20630se5-005_ultiva_lbl.pdf | https://www.drugbank.ca/drugs/DB00899 | https://www.ncbi.nlm.nih.gov/pubmed/16526829

Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. ULTIVA is a µ-opioid agonist with rapid onset and peak effect, and short duration of action. The µ-opioid activity of ULTIVA is antagonized by opioid antagonists such as naloxone. ULTIVA is indicated for IV administration: 1. As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. 2. For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. 3. As an analgesic component of monitored anesthesia care in adult patients.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Mu opioid receptor 231 Target ID: CHEMBL233 Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20630se5-005_ultiva_lbl.pdf	Agonist 2752

Conditions

Condition	Modality	Targets	Highest Phase	Product
Pain 619 Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20630se5-005_ultiva_lbl.pdf	Primary		Approved 8583	ULTIVA Approved Use ULTIVA is indicated for IV administration: 1.As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. 2.For continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. 3.As an analgesic component of monitored anesthesia care in adult patients. Launch Date 1996

C_max

Value	Dose	Co-administered	Analyte	Population
14 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
194 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL ACID blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
745 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
8080 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL ACID blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
11.4 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
2.48 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/14766712	6 μg/kg/h 1 times / day other, intravenous dose: 6 μg/kg/h route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL ACID blood	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

F_unbound

Value	Dose	Co-administered	Analyte	Population
30% DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020630s020lbl.pdf	0.5 μg/kg/min 1 times / day other, intravenous dose: 0.5 μg/kg/min route of administration: Intravenous experiment type: OTHER co-administered:		REMIFENTANIL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:8802	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8802
ZINC	ZINC000000538283	http://zinc15.docking.org/substances/ZINC000000538283

PubMed

Title	Date	PubMed
Magnesium as part of balanced general anaesthesia with propofol, remifentanil and mivacurium: a double-blind, randomized prospective study in 50 patients.	2001-11	11580778
The bispectral index during an anaphylactic circulatory arrest.	2001-10	11669440
Effect of age on recovery from remifentanil anaesthesia.	2001-10	11669432
Goal oriented general anesthesia for Cesarean section in a parturient with a large intracranial epidermoid cyst.	2001-10	11606346
Threshold-level repetitive transcranial electrical stimulation for intraoperative monitoring of central motor conduction.	2001-10	11599831
A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia.	2001-10	11574346
Effects of the opioid remifentanil on olfactory function in healthy volunteers.	2001-09-28	11669470
Effects of cerebrospinal fluid loss and epidural blood patch on cerebral blood flow in swine.	2001-09-19	11561258
A comparison of propofol and remifentanil for sedation and limitation of movement during periretrobulbar block.	2001-09	11578885
Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients.	2001-09	11578883
Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?	2001-09	11578882
Spontaneous movements, local reactions and pain on injection of rocuronium. A comparison between female and male patients.	2001-09	11576052
Effects of remifentanil/propofol in comparison with isoflurane on dynamic cerebrovascular autoregulation in humans.	2001-09	11576048
Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy.	2001-09	11553256
Potential hazard with syringe infusion pump.	2001-09	11531686
Facilitation of laryngeal mask airway insertion: effects of remifentanil administered before induction with target-controlled propofol infusion.	2001-09	11531680
The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria.	2001-09	11524316
Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane.	2001-09	11517126
Patient-controlled analgesia for labour using remifentanil: a feasibility study.	2001-09	11517125
Sevoflurane with remifentanil allows rapid tracheal intubation without neuromuscular blocking agents.	2001-08-10	11495870
[Esterase-metabolized remifentanil hydrochloride opioid (Ultiva-TM), a new step towards the solution of the problem of regulation of analgetic components of general anesthesia].	2001-08-10	11494899
Influence of hypotensive and normotensive anesthesia on platelet aggregability and hemostatic markers in orthognathic surgery.	2001-08-01	11672580
Remifentanil.	2001-08	11571418
[Mastocytosis: general anesthesia with remifentanil and sevoflurane].	2001-08	11530751
Target-controlled infusion or manually controlled infusion of propofol in high-risk patients with severely reduced left ventricular function.	2001-08	11505347
The use of remifentanil to facilitate the insertion of the laryngeal mask airway.	2001-08	11473861
Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy.	2001-08	11472282
[Remifentanil for palliative abdominal surgery in a patient with myasthenia gravis].	2001-07-12	11446948
Opioid chronopharmacology.	2001-07	11531909
Anaesthetic management of a child with a positive family history of malignant hyperthermia for posterior fossa surgery in the sitting position.	2001-07	11442873
Esmolol is not an alternative to remifentanil for fast-track outpatient gynecologic laparoscopic surgery.	2001-07	11429376
Monitored anesthesia care using remifentanil and propofol for awake craniotomy.	2001-07	11426102
Postoperative reading speed does not indicate implicit memory in elderly cardiac patients after propofol and remifentanyl anaesthesia.	2001-07	11421835
Outpatient laparoscopic adrenalectomy in patients with Conn's syndrome.	2001-06	11591947
Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery.	2001-06	11573581
Bispectral index monitoring in sevoflurane and remifentanil anesthesia. Analysis of drugs management and immediate recovery.	2001-06	11533541
Safety and efficacy of remifentanil infusion in craniosynostosis repair in infants.	2001-06	11455235
Effect of tracheal intubation or laryngeal mask airway insertion on intraocular pressure using balanced anesthesia with sevoflurane and remifentanil.	2001-06	11435050
Clonidine decreases propofol requirements during anaesthesia: effect on bispectral index.	2001-05	11575336
[Anesthesia in extreme obesity].	2001-05	11413802
[Droperidol and dimenhydrinate alone or in combination for prevention of postoperative nausea and vomiting].	2001-05	11413698
[General anesthesia with remifentanil in two cases of emergency cesarean section].	2001-05	11412735
Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia.	2001-04	11573626
Recovery from propofol anaesthesia supplemented with remifentanil.	2001-03	11573525
Comparison of effects of remifentanil and alfentanil on cardiovascular response to tracheal intubation in hypertensive patients.	2001-01	11575417
Recovery and neurological examination after remifentanil-desflurane or fentanyl-desflurane anaesthesia for carotid artery surgery.	2001-01	11575408
Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section.	2001-01	11575392
Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension.	2001	11534314
Use of remifentanil in combination with desflurane or propofol for ambulatory oral surgery.	2001	11534310
[Total intravenous anesthesia using remifentanil and propofol with midazolam co-induction in laparoscopic surgery of the gallbladder].	2001	11432253

Patents

Sample Use Guides

In Vivo Use Guide

Usual Adult Dose for Anesthesia Induction of Anesthesia: Continuous IV infusion: 0.5 to 1 mcg/kg/min. If endotracheal intubation is to occur in less than 8 minutes, an initial dose of 1 mcg/kg may be administered over 30 to 60 seconds. Maintenance of Anesthesia: With Nitrous Oxide, 0.4 mg/kg/min by continuous IV infusion. Infusion dose range: 0.1 to 2 mcg/kg/min. Supplemental IV bolus: 1 mcg/kg every 2 to 5 minutes.

Route of Administration: Intravenous

In Vitro Use Guide

Remifentanil (10(-8) - 10(-4) mol/ L) caused a concentration-dependent vasorelaxation in the human being artery rings.

Substance Class	Chemical Created by `admin` on `Wed Apr 02 08:50:56 GMT 2025` Edited by `admin` on `Wed Apr 02 08:50:56 GMT 2025`
Record UNII	P10582JYYK
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GI 87084X

Preferred Name

English

REMIFENTANIL

Official Name

English

RAMIFENTANYL

Common Name

English

Remifentanil [WHO-DD]

Common Name

English

REMIFENTANIL [MI]

Common Name

English

ULTIVA-

Common Name

English

remifentanil [INN]

Common Name

English

REMIFENTANYL

Common Name

English

REMIFENTANIL [VANDF]

Common Name

English

IDS-NR-005

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C67413